5.05
Owens Minor Inc stock is traded at $5.05, with a volume of 1.81M.
It is down -0.59% in the last 24 hours and down -37.65% over the past month.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
See More
Previous Close:
$5.08
Open:
$5.11
24h Volume:
1.81M
Relative Volume:
1.25
Market Cap:
$390.08M
Revenue:
$10.42B
Net Income/Loss:
$-38.77M
P/E Ratio:
-9.902
EPS:
-0.51
Net Cash Flow:
$323.54M
1W Performance:
-11.09%
1M Performance:
-37.65%
6M Performance:
-18.81%
1Y Performance:
-67.73%
Owens Minor Inc Stock (OMI) Company Profile
Name
Owens Minor Inc
Sector
Industry
Phone
(804) 723-7000
Address
10900 NUCKOLS ROAD, GLEN ALLEN, VA
Compare OMI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
OMI
Owens Minor Inc
|
5.05 | 420.98M | 10.42B | -38.77M | 323.54M | -0.51 |
![]()
MCK
Mckesson Corporation
|
689.45 | 83.49B | 377.60B | 3.35B | 5.67B | 25.08 |
![]()
COR
Cencora Inc
|
292.60 | 56.29B | 316.65B | 1.91B | 1.14B | 9.72 |
![]()
CAH
Cardinal Health Inc
|
148.10 | 35.75B | 222.58B | 1.57B | 1.85B | 6.45 |
![]()
HSIC
Henry Schein Inc
|
69.60 | 8.15B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
AHG
Akso Health Group Adr
|
1.77 | 701.93M | 2.22M | -5.63M | -1.68M | -0.24 |
Owens Minor Inc Stock (OMI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Jan-03-24 | Initiated | Barclays | Equal Weight |
Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Apr-26-22 | Resumed | Citigroup | Buy |
Apr-01-22 | Resumed | Credit Suisse | Neutral |
Mar-30-22 | Resumed | JP Morgan | Underweight |
Dec-17-20 | Upgrade | UBS | Neutral → Buy |
Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
Apr-23-20 | Resumed | Credit Suisse | Neutral |
Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
Jan-17-19 | Initiated | UBS | Neutral |
Nov-01-18 | Reiterated | Barclays | Underweight |
Oct-31-18 | Downgrade | BofA/Merrill | Buy → Neutral |
Mar-08-18 | Initiated | Barclays | Underweight |
Feb-27-18 | Resumed | BofA/Merrill | Buy |
Dec-19-17 | Downgrade | JP Morgan | Neutral → Underweight |
Sep-01-17 | Upgrade | Robert W. Baird | Underperform → Neutral |
Nov-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
Apr-21-16 | Downgrade | Robert W. Baird | Neutral → Underperform |
Mar-16-16 | Initiated | Credit Suisse | Underperform |
Dec-07-15 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Owens Minor Inc Stock (OMI) Latest News
Owens & Minor, Inc. shares rise 2.75% premarket after being mentioned as a prominent player in the traditional wound care market. - AInvest
Owens & Minor falls short of Q2 earnings forecasts amid divestiture plans - MSN
Owens & Minor refocuses on Patient Direct - HME News
Coliseum capital buys Owens & Minor (OMI) shares worth $8.1 million - Investing.com Nigeria
Owens & Minor secures $4.5B Defense Logistics Agency contract modification - MSN
Analysts' 4 Projections for Owens & Minor: Bullish to Bearish Sentiments - AInvest
Owens & Minor, Inc. (NYSE:OMI) Q2 2025 Earnings Call Transcript - Insider Monkey
UBS Adjusts Price Target on Owens & Minor to $7 From $13, Maintains Buy Rating - MarketScreener
UBS lowers Owens & Minor stock price target to $7 on disappointing outlook - Investing.com
Owens & Minor Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Owens & Minor Analysts Boost Their Forecasts After Q2 Results - Benzinga
Citigroup Maintains Buy Rating on Owens & Minor with PT Down to $7. - AInvest
Owens Minor 2025 Q2 Earnings Deepening Net Loss - AInvest
Owens & Minor: Q2 Earnings Snapshot - New Haven Register
Owens & Minor Inc (OMI) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Challenges - Yahoo Finance
Owens & Minor Inc (OMI) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Challenges By GuruFocus - Investing.com Canada
Owens & Minor Reports Q2 Results Amid Segment Sale - MSN
Owens & Minor Reports Q2 2025 Earnings and Strategic Shift - TipRanks
Owens & Minor shares rise 1.19% after-hours following Q2 earnings release and divestiture process. - AInvest
OWENS & MINOR INC/VA/ SEC 10-Q Report - TradingView
Owens & Minor: An Extreme Reached Amid Disastrous Results (Rating Upgrade) (NYSE:OMI) - Seeking Alpha
Owens & Minor (OMI.N) Sees Unusual 34% Intraday Drop – Technicals and Order-Flow Point to Liquidity Drought - AInvest
Owens & Minor Q2 2025 Earnings Call Transcript - MarketBeat
Owens & Minor (OMI) Shares Plummet After Disappointing Outlook - GuruFocus
Owens & Minor's Strategic Transition: Is the Pure-Play Patient Direct Model Worth the Pain? - AInvest
Owens & Minor's Q2 2025: Unraveling Key Contradictions in Financials and Growth Trajectories - AInvest
Owens & Minor Pushes Forward, Transitions To 'Pure-Play' Patient Direct Business - Benzinga
Owens & Minor, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:OMI) - Seeking Alpha
Owens & Minor Shares Fall After Q2 Adjusted Earnings, 2025 Outlook Miss Expectations - MarketScreener
Owens & Minor tanks as FY profit outlook falls short of estimates - MSN
Owens & Minor stock tanks after Q2 miss, guidance (OMI:NYSE) - Seeking Alpha
Owens & Minor tumbles after Q2 revenue miss - TradingView
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings, Technology Stocks Fall - AInvest
Transcript : Owens & Minor, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings - Benzinga
Earnings call transcript: Owens & Minor misses Q2 2025 EPS forecast, stock tumbles - Investing.com
Owens & Minor Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Owens & Minor, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Owens & Minor Reports Second Quarter 2025 Financial Results11.08.25News - Ariva
Owens & Minor's Q2 2025 Earnings Miss: A Sell Signal or a Value Opportunity? - AInvest
Owens & Minor Reports Second Quarter 2025 Financial Results | OM - GuruFocus
Owens & Minor Q2 2025 slides: Company maintains positive outlook despite challenges - Investing.com
Owens & Minor misses Q2 earnings estimates as it prepares for divestiture - Investing.com Australia
Owens & Minor misses Q2 earnings estimates as it prepares for divestiture By Investing.com - Investing.com South Africa
Owens & Minor misses Q2 revenue, adjusted EPS expectations - MarketScreener
Owens & Minor : Q2 Earnings 2025 Press Release - MarketScreener
Owens & Minor : Q2 Earnings 2025 Presentation - MarketScreener
Owens & Minor, Telephone And Data Systems And 3 Stocks To Watch Heading Into Monday - 富途牛牛
Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 EarningsOwens & Minor (NYSE:OMI) - Benzinga
Owens & Minor Q2 Earnings Preview: Revenue Expected at $2.73 Billion, EPS at -$0.31 - AInvest
Owens & Minor (OMI.N) Surges 12.36%: What’s Behind the Sharp Intraday Move? - AInvest
Owens Minor Inc Stock (OMI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Owens Minor Inc Stock (OMI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
Coliseum Capital Management, L | 10% Owner |
Apr 09 '25 |
Buy |
7.39 |
225,000 |
1,662,750 |
11,482,955 |
Coliseum Capital Management, L | 10% Owner |
Apr 08 '25 |
Buy |
7.96 |
105,000 |
835,800 |
11,257,955 |
Coliseum Capital Management, L | 10% Owner |
Apr 10 '25 |
Buy |
7.19 |
80,000 |
575,200 |
11,562,955 |
Coliseum Capital Management, L | 10% Owner |
Apr 07 '25 |
Buy |
7.84 |
240,000 |
1,881,600 |
11,152,955 |
Coliseum Capital Management, L | 10% Owner |
Apr 03 '25 |
Buy |
8.53 |
160,000 |
1,364,800 |
10,784,599 |
Coliseum Capital Management, L | 10% Owner |
Apr 04 '25 |
Buy |
8.14 |
128,356 |
1,044,818 |
10,912,955 |
Coliseum Capital Management, L | 10% Owner |
Feb 28 '25 |
Buy |
9.39 |
1,738,511 |
16,324,618 |
9,469,698 |
Coliseum Capital Management, L | 10% Owner |
Mar 04 '25 |
Buy |
9.75 |
800,000 |
7,800,000 |
10,624,599 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):